Does SOTAGLIFLOZIN Cause Product use issue? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Product use issue have been filed in association with SOTAGLIFLOZIN (INPEFA). This represents 4.2% of all adverse event reports for SOTAGLIFLOZIN.
20
Reports of Product use issue with SOTAGLIFLOZIN
4.2%
of all SOTAGLIFLOZIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product use issue From SOTAGLIFLOZIN?
Of the 20 reports, 5 (25.0%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTAGLIFLOZIN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does SOTAGLIFLOZIN Cause?
Dizziness (51)
Diarrhoea (45)
Therapy interrupted (28)
Death (24)
Off label use (24)
Dyspnoea (22)
Headache (21)
Urinary tract infection (21)
Nausea (18)
Fungal infection (16)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which SOTAGLIFLOZIN Alternatives Have Lower Product use issue Risk?
SOTAGLIFLOZIN vs SOTALOL
SOTAGLIFLOZIN vs SOTATERCEPT
SOTAGLIFLOZIN vs SOTATERCEPT-CSRK
SOTAGLIFLOZIN vs SOTORASIB
SOTAGLIFLOZIN vs SOTROVIMAB